Skip to Main Content

Paper Details

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
J Immunother
14
2020
Author NameAffiliation
Izak FaienaInstitute of Urologic Oncology.
Karim ChamieInstitute of Urologic Oncology.
Alexandra DrakakiInstitute of Urologic Oncology.
Alexandra DrakakiDavid Geffen School of Medicine at University of California.
  • 1 - 4

Datasets

Release 1.2